Pulmatrix Stock News

Presentation will showcase Company's patented iSPERSE™ technology and positive topline results from Phase 1 study of PUR3100 for acute migraine LEXINGTON, Mass. , May 24, 2023 /PRNewswire/ -- Pulmat

LEXINGTON, Mass. , Jan. 23, 2023 /PRNewswire/ -- Pulmatrix, Inc. (NASDAQ: PULM), a clinical-stage biopharmaceutical company developing innovative inhaled therapies to address serious disease using its

Merus N.V. (MRUS) delivered earnings and revenue surprises of 34.85% and 36.28%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Arbutus (ABUS) delivered earnings and revenue surprises of 15.38% and 118.16%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

As Pulmatrix executes a reverse stock split, shares of the tiny pharmaceutical company appear to be defying gravity.

U.S. companies are cutting ties with Russia due to the war with Ukraine and we're going over which ones traders need to know about. The post Which U.S. Companies Are Cutting Ties With Russia?

A 1-for-20 reverse split of Pulmatrix Inc (NASDAQ: PULM) stock has gone into effect. These are the details.

Here''s a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Lilly''s Co-developed Diabetes Drug Jardiance Gets Label Expansion To Treat Hear Failure Lilly & Company, Inc. (NYSE: LLY ) announced the U.S. Food and Drug Administration has approved Jardiance, 10 mg, to reduce the risk of cardiovascular death and hospitalization for heart failure in adults with heart failure. Lilly is co-developing the drug with Boehringer Ingelheim. Pliant Commences Mid-stage Study of Idiopathic Pulmonary Fibrosis Treatment Following Positive Independent Safety Review Pliant Therapeutics, Inc. (NASDAQ: PLRX ) said, following a positive independent Data Safety Monitoring Board safety review, it has begun rolling in a Phase 2a trial of PLN-74809 at 320 mg dosed once daily for at least six months in patients with idiopathic pulmonary fibrosis. The stock was up 2.02% at $8.59 in premarket trading. Aquestive Announces FDA Clearance For Study Of Allergy Treatment Candidate AQST-109 Aquestive Therapeutics, Inc. (NASDAQ: AQST ) announced the clearance of its investigational new Drug Application from the FDA for its drug candidate AQST-109 epinephrine oral film for the emergency treatment of severe allergic reactions, including anaphylaxis.

Pulmatrix (PULM) trades 14.4% down after hours on announcing a 1-for-20 reverse split of its common stock, effective Feb.28, 2022 after market close.The stock is expected to trade on…

Pulmatrix Inc (PULM) shares closed today at 0.8% above its 52 week low of $0.40, giving the company a market cap of $22M. The stock is currently down 7.8% year-to-date, down 69.7% over the past 12 months, and down 93.7% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 1.9%. Trading Activity Trading volume this week was 67.2% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.3. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -13.7% The company's stock price performance over the past 12 months lags the peer average by 320.9% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Pulmatrix Inc (PULM) shares closed today at 0.8% above its 52 week low of $0.40, giving the company a market cap of $22M. The stock is currently down 7.8% year-to-date, down 69.7% over the past 12 months, and down 93.7% over the past five years. This week, the Dow Jones Industrial Average fell 0.5%, and the S&P 500 fell 1.7%. Trading Activity Trading volume this week was 67.2% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.3. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought.The stock closed at 4.8% lower than its 5-day moving average, 15.6% lower than its 20-day moving average, and 42.0% lower than its 90-day moving average. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 16.8% The company's stock price performance over the past 12 months lags the peer average by 479.0% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Pulmatrix, Inc. (NASDAQ:PULM) with the stream of 0.00% also noticed, India Lumen Technologies, Inc. (NYSE:LUMN) encountered a rapid change of 0.63% in the last hour of Thursdays trading session. Pulmatrix, The post Volume Buzzers: Pulmatrix, Inc. (NASDAQ:PULM), Lumen Technologies, Inc. (NYSE:LUMN) appeared first on Stocks Equity .

Pulmatrix, Inc. (NASDAQ:PULM) with the stream of 0.95% also noticed, India Tanzanian Gold Corporation (AMEX:TRX) encountered a rapid change of 3.82% in the last hour of Tuesdays trading session. Pulmatrix, The post Glistering Stock: Pulmatrix, Inc. (NASDAQ:PULM), Tanzanian Gold Corporation (AMEX:TRX) appeared first on Stocks Equity .

Pulmatrix Inc (PULM) shares closed 4.6% lower than its previous 52 week low, giving the company a market cap of $26M. The stock is currently down 60.1% year-to-date, down 59.4% over the past 12 months, and down 92.8% over the past five years. This week, the Dow Jones Industrial Average fell 1.7%, and the S&P 500 fell 2.0%. Trading Activity Trading volume this week was 36.9% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.2. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 677.4% The company's stock price performance over the past 12 months lags the peer average by 248.2% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Pulmatrix, Inc. (NASDAQ:PULM) with the stream of -0.63% also noticed, India Puxin Limited (NYSE:NEW) encountered a rapid change of -2.15% in the last hour of Fridays trading session. Pulmatrix, Inc. The post Up to Date Stock in scrutiny: Pulmatrix, Inc. (NASDAQ:PULM), Puxin Limited (NYSE:NEW) appeared first on Stocks Equity .